Deutsch English Français

Contact

EP2233495

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP2233495

EP2233495 - GLYCOSYLATED GLYCOPEPTIDE ANTIBIOTIC DERIVATIVE [Right-click to bookmark this link]
Status	The application is deemed to be withdrawn Status updated on 03.01.2014 Database last updated on 20.09.2024
Most recent event Tooltip	03.01.2014	Application deemed to be withdrawn	published on 05.02.2014 [2014/06]
Applicant(s)	For all designated states Shionogi & Co., Ltd. 1-8 Doshomachi 3-chome Chuo-ku Osaka-shi Osaka 541-0045 / JP
	[N/P]
Former [2010/39]	For all designated states Shionogi & Co., Ltd. 1-8 Doshomachi 3-chome Chuo-ku Osaka-shi Osaka 541-0045 / JP
Inventor(s)	01 / MATSUI, Kouhei c/o Shionogi&Co. Ltd. 12-4, Sagisu 5-chome Fukushima-ku Osaka-shi Osaka 553-0002 / JP
	02 / MINAGAWA, Kazuyuki c/o Shionogi&Co. Ltd. 12-4, Sagisu 5-chome Fukushima-ku Osaka-shi Osaka 553-0002 / JP
	03 / YOSHIDA, Osamu c/o Shionogi&Co. Ltd. 12-4, Sagisu 5-chome Fukushima-ku Osaka-shi Osaka 553-0002 / JP
	04 / MORIMOTO, Kenji c/o Shionogi&Co. Ltd. 1-1, Futabacho 3-chome Toyonaka-shi Osaka 561-0825 / JP
	05 / OGATA, Yuuki c/o Shionogi&Co. Ltd. 12-4, Sagisu 5-chome Fukushima-ku Osaka-shi Osaka 553-0002 / JP
	[2010/39]
Representative(s)	Webster, Jeremy Mark, et al Mewburn Ellis LLP Aurora Building Counterslip Bristol BS1 6BX / GB
	[N/P]
Former [2010/39]	Webster, Jeremy Mark, et al Mewburn Ellis LLP 33 Gutter Lane London EC2V 8AS / GB
Application number, filing date	08863497.7	25.12.2008
	[2010/39]
	WO2008JP73511
Priority number, date	JP20070333408	26.12.2007 Original published format: JP 2007333408
	[2010/39]
Filing language	JA
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	WO2009081958
	Date:	02.07.2009
	Language:	JA
	[2009/27]
	Type:	A1 Application with search report
	No.:	EP2233495
	Date:	29.09.2010
	Language:	EN
	[2010/39]
Search report(s)	International search report - published on:	JP	02.07.2009
	(Supplementary) European search report - dispatched on:	EP	24.02.2011
Classification	IPC:	C07K9/00, C07G11/00, A61K38/00, A61P9/00, A61P31/04	[2010/39]
	CPC:	C07K9/008 (EP,US); A61P11/00 (EP); A61P17/00 (EP); A61P19/02 (EP); A61P31/04 (EP); A61P9/00 (EP); (+) A61K38/00 (EP,US) (-)
Designated contracting states	AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR [2010/39]
Extension states	AL	12.07.2010
	BA	12.07.2010
	MK	12.07.2010
	RS	12.07.2010
Title	German:	ANTIBIOTISCHES GLYKOSILIERTES GLYKOPEPTIDDERIVAT	[2010/39]
	English:	GLYCOSYLATED GLYCOPEPTIDE ANTIBIOTIC DERIVATIVE	[2010/39]
	French:	DÉRIVÉ ANTIBIOTIQUE DE GLYCOPEPTIDE GLYCOSYLÉ	[2010/39]
Entry into regional phase	13.07.2010	Translation filed
	12.07.2010	National basic fee paid
	12.07.2010	Search fee paid
	12.07.2010	Designation fee(s) paid
	12.07.2010	Examination fee paid
Examination procedure	13.07.2010	Examination requested [2010/39]
	19.09.2011	Amendment by applicant (claims and/or description)
	23.04.2013	Despatch of a communication from the examining division (Time limit: M04)
	04.09.2013	Application deemed to be withdrawn, date of legal effect [2014/06]
	01.10.2013	Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2014/06]
Divisional application(s)	The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 23.04.2013
Fees paid	Renewal fee
	21.12.2010	Renewal fee patent year 03
	20.12.2011	Renewal fee patent year 04
	20.12.2012	Renewal fee patent year 05
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:	Search	[ID] - RITTER THOMAS K ET AL, "A programmable one-pot oligosaccharide synthesis for diversifying the sugar domains of natural products: a case study of vancomycin.", ANGEWANDTE CHEMIE (INTERNATIONAL ED. IN ENGLISH) 6 OCT 2003 LNKD- PUBMED:14533156, (20031006), vol. 42, no. 38, ISSN 1433-7851, pages 4657 - 4660, XP002620449 [ID] 1-15 * the whole document * * in particular compound 4e and page 4659, first paragraph * DOI: http://dx.doi.org/10.1002/anie.200351534
	International search	[Y]US2004259228 (THORSON JON [US]);
		[Y]WO2006057288 (UNIV NAGOYA NAT UNIV CORP [JP], et al);
		[Y]JP2006503015 (K.U. LEUVEN RESEARCH AND DEVELOPMENT);
		[Y]JP2003026725 (TOYO BOSEKI);
		[A]JPH04108800 (LILLY CO ELI);
		[A]JP2006528188 (THERAVANCE, INC.);
		[A]JP2002520422 (PRINCETON UNIVERSITY);
		[A]JP2007505841 (ALPHARMA APS);
		[A]WO2006057303 (UNIV NAGOYA NAT UNIV CORP [JP], et al);
		[A]WO0181373 (MERCK & CO INC [US]);
		[A]JPH01240196 (SHIONOGI & CO);
		[A]WO0041710 (UNIV PRINCETON [US]);
		[A]WO0181372 (UNIV PRINCETON [US]);
		[A]JP2001163898 (SHIONOGI & CO);
		[A]WO2006003456 (ISIS INNOVATION [GB], et al)
		[Y] - GRIFFITH B.R. ET AL., "'Sweetening' natural products via glycorandomization", CURRENT OPINION BIOTECHNOLOGY, (2005), vol. 16, doi:doi:10.1016/j.copbio.2005.10.002, pages 622 - 630, XP005173494 DOI: http://dx.doi.org/10.1016/j.copbio.2005.10.002
		[Y] - SALAS, J.A ET AL., "Engineering the glycosylation of natural products in actinomycetes", TRENDS IN MICROBIOL., (20070406), vol. 15, no. 5, doi:doi:10.1016/j.tim.2007.03.004, pages 219 - 232, XP022053528 DOI: http://dx.doi.org/10.1016/j.tim.2007.03.004
		[Y] - LU.W. ET AL., "Characterization of a regiospecific epivancosaminyl transferase GtfA and enzymatic reconstitution of the antibiotic chloroeremomycin", PROC.NATL.ACAD.SCI.USA, (2004), vol. 101, no. 13, pages 4390 - 4395
		[Y] - OBERTHUER, M. ET AL., "A systematic investigation of the synthetic utility of glycopeptides glycosyltransferases", J.AM.CHEM. SOC., (2005), vol. 127, no. 30, pages 10747 - 10752
		[Y] - MULICHAK, A.M. ET AL., "Structure of the UDP- glucosyltransferase GtfB that modifies the heptapeptide aglycone in the biosynthesis of vancomycin group antibiotics", STRUCTURE, (2001), vol. 9, pages 547 - 557
		[A] - FU, X. ET AL., "Antibiotic optimization via in vitro glycorandomization", NATURE BIOTECH., (2003), vol. 21, no. 12, pages 1467 - 1469
		[A] - GRDADOLNIK, S.G. ET AL., "Vancomycin: Conformational consequences of the sugar substituent.", J. MEDICINAL CHEM., (1998), vol. 41, pages 2090 - 2099
		[A] - GRIFFITH, B.R. ET AL., "Model for antibiotic optimization via neoglycosylation: synthesis of liponeoglycopeptides active against VRE.", J.AM. CHEM.SOC., (2007), vol. 129, no. 26, doi:doi:10.1021/ja068602r, pages 8150 - 8155, XP002488143 DOI: http://dx.doi.org/10.1021/ja068602r
	by applicant	JPH01240196
		JP2001163898
		WO2006003456
		US2005239689
		US2003068669
		US2004259228
		US2005266523
		WO2004019970
		WO0181373
		WO0181372
		WO0069893
		WO0059528
		WO0042067
		WO0004044
		WO9303060
		EP0301785
		EP0273727
		WO2006057303
		JPS61251699
		JPH07258289
		WO9630401
		WO0039156
		JP2000302687
		WO2004044222
		US4639433
		US4643987
		US4497802
		US4698327
		US5591714
		US5840684
		US5843889
		EP0802199
		EP0801075
		EP0667353
		WO9728812
		WO9738702
		WO9852589
		WO9852592
		- ANGEWANDTE CHEMIE, INTERNATIONAL EDITION, (2003), vol. 42, no. 38, pages 4657 - 4660
		- JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, (2005), vol. 127, no. 30, pages 10747 - 10752
		- PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, (2004), vol. 101, no. 13, pages 4390 - 4395
		- CHEMISTRY-AN ASIAN JOURNAL, (2006), vol. 1, pages 445 - 452
		- CURRENT OPINION IN BIOTECHNOLOGY, (2005), vol. 16, pages 622 - 630
		- NATURE BIOTECHNOLOGY, (2003), vol. 21, no. 12, pages 1467 - 1469
		- ACS CHEMICAL BIOLOGY, (2006), vol. 1, no. 8, pages 499 - 504
		- ACTIVITY RESEARCH, (2006), vol. 72, no. 1, pages 20 - 33
		- BIOORGANIC & MEDICAL CHEMISTRY LETTERS, (2005), vol. 15, no. 16, pages 3801 - 3805
		- ORGANIC LETTERS, (2005), vol. 7, no. 8, pages 1513 - 1515
		- CHEMISTRY & BIOLOGY, (2005), vol. 12, no. 1, pages 131 - 140
		- ANGEWANDTE CHEMIE, (2003), vol. 42, no. 38, pages 4657 - 4660
		- JOURNAL OF MEDICINAL CHEMISTRY, (2003), vol. 46, no. 13, pages 2755 - 2764
		- TETRAHEDRON, (2002), vol. 58, no. 32, pages 6585 - 6594
		- BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, (2002), vol. 12, no. 6, pages 849 - 852
		- CHEMISTRY - - A EUROPEAN JOURNAL, (2001), vol. 7, no. 17, pages 3798 - 3823
		- JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, (2000), vol. 122, no. 50, pages 12608 - 12609
		- JOURNAL OF ANTIBIOTICS, (1998), vol. 51, no. 5, pages 525 - 527
		- EXPERT OPINION ON THERAPEUTIC PATENTS, (2004), vol. 14, no. 2, pages 141 - 173
		- J. AM. CHEM. SOC., (1996), vol. 118, pages 13107 - 13108
		- J. AM. CHEM. SOC., (1997), vol. 119, pages 12041 - 12047
		- J. AM. CHEM. SOC., (1994), vol. 116, pages 4573 - 4580
		- EXPERT OPIN. THER. PATENTS, (2004), vol. 14, pages 141 - 173
		- J. MED. CHEM., (1965), vol. 8, pages 18 - 22
		- J. CHEM. SOC., CHEM. COMMUN., (1988), pages 1306 - 1307
		- BIOCHEMISTRY, (2001), vol. 40, no. 15, pages 4745 - 4755
	- J. AM. CHEM. SOC., (2005), vol. 127, no. 30, pages 10747 - 10752
	- PROC. NATL. ACAD. SCI. U.S.A., (2004), vol. 101, no. 13, pages 4390 - 4395
	- CHEM. ASIAN. J., (2006), vol. 1, pages 445 - 452

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 34p